Sharemaestro company-news research for Cipher Pharmaceuticals Inc. (CPH), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
TOR
Canada
Provisional evidence
Company news sentiment
CPH news sentiment
Cipher Pharmaceuticals Inc.
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
30-day score52Neutral is 50
Early balanced news score
27/100 evidence confidence
100% direct company focus
8 current stories across 5 publishers
Current company news
Early balanced news score
8 company-specific stories are available, but there are not yet enough fresh stories from separate publishers for a firm reading.
Observed headline tone63/100
→
Reliability-adjusted score52/100
Latest source headline
Cipher Pharmaceuticals Reports Second Quarter 2026 Results
finance.yahoo.com · 11 Aug 2026 21:00
Freshness, source quality and evidence depth temper uncertain readings toward 50; confidence remains a separate reliability measure.
What supports the score
8 current stories are mapped specifically to CPH.
The read spans 5 publishers rather than depending on one outlet.
What limits the score
The stories agree, but freshness-weighted evidence is only 0.131.
Evidence confidence is 27/100, below the threshold for a firm classification.
52/100
News scoreEarly balanced news score
27/100
Confidencethin evidence
100%/100
Company news8 company stories
95/100
Story agreement5/100 difference
News history
Daily score and story count over 30 days
15 Jul30 Jul13 Aug
News scoreStory count50 baseline
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence3
0.131 after freshness weightingSource breadth100
5 independent publishersCompany relevance100
share tied directly to this companyFreshness65
recency-weighted evidenceAgreement95
how closely stories agreePublisher mix25
less reliance on one publisherPrice and news history
News score and weekly price over 26 weeks
Company-specific news is present, but the evidence has not yet earned enough independent, fresh information weight for price confirmation to be treated as a firm signal.
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
WeekNews scoreCloseWeekly move
07 Aug 202650CAD 17.55+4.3%
31 Jul 202650CAD 16.83+3.6%
24 Jul 202650CAD 16.25-0.9%
17 Jul 202650CAD 16.4-4.3%
10 Jul 202650CAD 17.13-0.2%
03 Jul 202650CAD 17.17+4.6%
Provisional evidence
News subjects
What is shaping the score
Market update515 stories · 62%
Earnings632 stories · 25%
Capital return501 stories · 12%
Source mix
Where the evidence comes from
Wealth Awesome503 stories · 38%
marketscreener.com502 stories · 25%
finance.yahoo.com651 stories · 12%
Kalkine Media571 stories · 12%
scanx.trade501 stories · 12%
Recurring subjects
Subjects appearing most often
Earnings Per Share1Earnings1EARNINGS PER SHARE1EARNINGS1Balance Sheet1BALANCE SHEET1
Earlier readings
How the score has changed
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
03 Jul50 neutral13 Aug 16:08
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 13 Aug 16:08 | 51 | +0 | 26/100 (-2) | 8 (0) | Provisional |
| 11 Aug 23:59 | 51 | +1 | 28/100 (+2) | 8 (0) | Provisional |
| 02 Aug 23:59 | 50 | +0 | 26/100 (+3) | 8 (0) | Provisional |
| 31 Jul 23:59 | 50 | +0 | 23/100 (-4) | 8 (+1) | Provisional |
| 24 Jul 23:59 | 50 | +0 | 27/100 (+2) | 7 (+1) | Provisional |
| 23 Jul 23:59 | 50 | +0 | 25/100 (-1) | 6 (+1) | Provisional |
| 20 Jul 23:59 | 50 | +0 | 26/100 (0) | 5 (+1) | Provisional |
| 15 Jul 23:59 | 50 | +0 | 26/100 (-1) | 4 (+2) | Provisional |
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
#165Tone
finance.yahoo.comDirect company coverage
Cipher Pharmaceuticals Reports Second Quarter 2026 Results
(All figures are presented in U.S. Dollars) Epuris® sales were $4.1 million during the quarter, a year-over-year increase of 14% compared to Q2 2025 and a sequential increase of 4% over Q1 2026 Letter of Intent executed with the pan-Canadian Pharmaceutical Alliance, securing expanded public reimbursement and enhancing patient access to Epuris® across Canada Launched a stocking program to have Natroba™ and/or its authorized generic Spinosad 'Available at Walmart' across the U.S. Adjusted EBITDA1of $14.6 million for the first half of 2026, a year-over-year increase of 6% compared to the first ha
BALANCE SHEETBalance SheetEARNINGSEARNINGS PER SHAREEarningsEarnings Per Share
- Published
- 11 Aug 2026 21:00
- News subject
- Earnings
- Why this score
- Positive financial language
- How it is used
- Direct company coverage
- Weighted influence
- High · 85.6% · 1.8d old
- Duplicates
- 2 consolidated
#250Tone
scanx.tradeDirect company coverageScored from headlineSource lookup
Cipher Pharmaceuticals schedules Q2 2026 earnings release and call
- Published
- 02 Aug 2026 18:38
- News subject
- Earnings
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Medium · 12.1% · 10.9d old
- Duplicates
- 1 consolidated
#350Tone
Wealth AwesomeDirect company coverageScored from headlineSource lookup
What's Going On With Cipher Pharmaceuticals Inc Stock Monday?
- Published
- 31 Jul 2026 13:00
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Low · 0.4% · 13.1d old
- Duplicates
- 1 consolidated
#457Tone
Kalkine MediaDirect company coverageScored from headlineSource lookup
Cipher Pharmaceuticals (TSX:CPH) Gains Focus After Recent Updates
- Published
- 24 Jul 2026 22:20
- News subject
- Market update
- Why this score
- Positive financial language
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 19.7d old
- Duplicates
- 1 consolidated
#550Tone
Wealth AwesomeDirect company coverageScored from headlineSource lookup
Why Cipher Pharmaceuticals Inc stock is gaining today
- Published
- 23 Jul 2026 10:07
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 21.3d old
- Duplicates
- 1 consolidated
#650Tone
marketscreener.comDirect company coverageScored from headlineSource lookup
Cipher Pharmaceuticals Inc.'s Equity Buyback announced on May 1, 2025, has expired.
- Published
- 20 Jul 2026 16:57
- News subject
- Capital return
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Low · 1.9% · 24.0d old
- Duplicates
- 1 consolidated
#750Tone
marketscreener.comDirect company coverageScored from headlineSource lookup
Cipher Pharmaceuticals Inc. and Pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of Epuris
- Published
- 15 Jul 2026 16:45
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 29.0d old
- Duplicates
- 1 consolidated
#850Tone
Wealth AwesomeDirect company coverageScored from headlineSource lookup
Why Cipher Pharmaceuticals Inc stock is tanking today
- Published
- 15 Jul 2026 02:02
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 29.6d old
- Duplicates
- 1 consolidated
Earlier company news
CPH news archive
Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above. Where an early legacy import did not retain its canonical URL, the headline links to an exact publisher-aware source lookup instead of inventing an article address.
Jul
07
2026
MT NewswiresArchivedLegacy headline · tone unscoredLegacy source lookup
InMed Pharmaceuticals Amends Deal With Mentari Therapeutics
- Published
- 7 Jul 2026 08:52
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
03
2026
TradingViewArchivedLegacy headline · tone unscoredLegacy source lookup
Cipher Pharmaceuticals Inc. Actuals & Estimates (TSX:CPH)
- Published
- 3 Jul 2026 05:52
- Catalyst
- Legacy snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.